These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


713 related items for PubMed ID: 12721916

  • 21. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J.
    Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
    Abd Elaziz KM, Sabbour SM, Dewedar SA.
    Vaccine; 2010 Nov 03; 28(47):7563-8. PubMed ID: 20797454
    [Abstract] [Full Text] [Related]

  • 25. The elimination of indigenous measles transmission in England and Wales.
    Ramsay ME, Jin L, White J, Litton P, Cohen B, Brown D.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S198-207. PubMed ID: 12721914
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G, Hoon HB, Ong A, Chua LT, Kai CS, Tai GK.
    Southeast Asian J Trop Med Public Health; 2006 Jan 15; 37(1):96-101. PubMed ID: 16771219
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA, Suleiman AJ, Robertson SE, Malankar P, Al-Khusaiby S, Helfand RF, Brown D, Bellini WJ, Sutter RW.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
    Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R.
    Am J Infect Control; 2006 Nov 15; 34(9):588-92. PubMed ID: 17097454
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Progress toward measles eradication in the region of the Americas.
    De Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S102-10. PubMed ID: 12721900
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Nov 24; 49(46):1048-50, 1059. PubMed ID: 11105768
    [Abstract] [Full Text] [Related]

  • 39. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.
    Kelly HA, Gidding HF, Karapanagiotidis T, Leydon JA, Riddell MA.
    BMC Public Health; 2007 Jun 08; 7():99. PubMed ID: 17555601
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 36.